GRF, GBG, NIV, MSLP, PWRM - Stock Report From DrStockPick.com!

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases.
By: Karl McMahon
 
Dec. 10, 2010 - PRLog -- Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.

Alzheimer's disease is among the most well known form of dementia, a broad term when it comes to forgetfulness and other intellectual abilities critical enough to obstruct everyday life. Alzheimer's diseases is the reason for 50 to seventy per cent of dementia cases.

Alzheimer's gets worse over time. Alzheimer's disease is a developing condition, at which symptoms slowly intensify over a period of time. Continuing, memory loss is mild, however with late-stage Alzheimer's disease, people lose the ability to hold on a dialogue as well as react to their surroundings. Alzheimer's is the 6th main source of death in the united states. People with Alzheimer's are living an average of eight years following an individual's symptoms developing into being recognizable to many others, but yet survival may range from three to 20 years, based upon years of age and various medical ailments.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

*****************************************
MusclePharm Corporation  announced it has reached an agreement to raise $1.4 million through a convertible promissory note and registration agreement with an accredited investor.

"We are very pleased with the successful completion of the agreement with the investor and believe this capital will support our capital requirements for growth," commented Brad Pyatt, MusclePharm's Chief Executive Officer. "We appreciate our investor's confidence in MusclePharm as we continue to execute our long-term growth strategy."

This capital raise, combined with the previously released fulfillment agreement with IVitals, further enhances the Company's overall financial strength for future long-term profitable growth. Management will continue to focus on the development, sales & marketing of MusclePharm's growing portfolio of nutritional supplement products.

MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen.

*****************************************

NIVS IntelliMedia Technology Group, Inc.  announced that at the recent merchandising conference at the Huizhou Crown Plaza Hotel where a new series of NIVS branded mobile phones were introduced, the Company received orders equal to $2.98 million for various new mobile phones. More than 700 distributors, wholesalers and agents participated in the two day event. The introduction of the new NIVS mobile phones including a promotional plan occurred, and orders representing the $2.98 million in sales of the mobile phones were from the provinces of Guangdong, Guangxi, Hunan, Hubei, Hebei, and Neimeng to name a few and also from major cities like Guangzhou, Beijing, Chongqing and Shenzhen. The Company believes final orders from the conference may exceed $4 million.

NIVS IntelliMedia Technology Group, Inc. and its subsidiaries engage in the design, manufacture, marketing, and sale of consumer electronic products.

*****************************************

Great Basin Gold Ltd.  announced that Great Basin’s Hollister Mine (Hollister) in Nevada was notified by letter from the Federal Mine Safety and Health Administration (MSHA) that MSHA had conducted a “pattern” of violation screening pursuant to Section 104(e) of the Federal Mine Safety and Health Act of 1977 (the Act). The letter stated that MSHA has initially concluded that a potential pattern of violations exists at Hollister and set out a process by which Hollister may work with MSHA to avoid any further sanctions pursuant to that program.

Great Basin Gold Limited, through its subsidiaries, engages in the acquisition, exploration, development, and trial mining of precious metal deposits.

*****************************************

Eagle Capital Growth Fund, Inc.  declared a year-end annual cash dividend of $0.28 per share. The record date for this dividend is December 17, 2010, and the payment date is December 29, 2010. On a preliminary basis, this dividend represents a combination of net investment income of $0.0757 per share, and short-term capital gains of $0.2043 per share. The net investment income is derived entirely from “qualified” dividends for U.S. Federal income tax purposes. This tax information is subject to change. Shareholders will receive definitive information with respect to U.S. Federal income tax treatment in the ordinary course. In addition, shareholders can access definitive tax information by going to the Fund’s website after year-end.

************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!



Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (MSLP.OB).
End
Source:Karl McMahon
Email:***@drstockpick.com Email Verified
Tags:(mslp.ob), American Public Health Association, Amex:gbg, Amex:grf, Amex:niv, Amino Acids
Industry:Business, Financial, Stocks
Account Email Address Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share